IP Library Granted Patent US 7,432,104
Granted Patent B2
US 7,432,104 · App. 10/486,408 · Granted Oct 7, 2008

Methods for the culture of human embryonic stem cells on human feeder cells

Assignee: BresGen Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,432,104
App. No.
10/486,408
Granted
Oct 7, 2008
Kind
B2
Abstract

Methods and cell culture medium for the generation of human pluripotent embryonic stem cells are disclosed. Human embryonic stem cells are cultured with human granulosa feeder cells, muscle cells, Fallopian ductal epithelial cells, bone marrow stromal cells, and skin fibroblasts and the embryonic stem cells maintain their pluripotent phenotype. The human pluripotent embryonic stem cells can be cultured without feeder cells, and in the presence of supplemental growth factors. The human pluripotent embryonic stem cells can be alternatively cultured with conditioned medium obtained from a cell culture capable of maintaining human embryonic stem cells in a pluripotent state, wherein the cell culture is a human granulosa cell culture.

Claims (33)

1. A human pluripotent stem cell culture, comprising a human embryonic stem cell and a human feeder cell, wherein the human feeder cell is selected from the group consisting of a fetal skin fibroblast cell and a skin keloid fibroblast cell, and wherein the human feeder cell maintains the human embryonic stem cell in an undifferentiated state for at least two passages.

2. The human pluripotent embryonic stem cells culture of claim 1 , where the human feeder cell is a skin keloid fibroblast cell.

3. The human embryonic stem cell culture of claim 1 , wherein the skin keloid fibroblast cell is ATCC deposit number CRL-1762.

4. The human pluripotent embryonic stem cells culture of claim 1 , where the human feeder cell is a fetal skin fibroblast cell.

5. A method of maintaining a human embryonic stem cell culture in an undifferentiated state for at least two passages, comprising culturing a human embryonic stem cell on a human feeder cell layer, wherein the human feeder cell is selected from the group consisting of a fetal skin fibroblast cell and a skin keloid fibroblast cell.

6. The method of claim 5 , wherein the human feeder cell is a skin keloid fibroblast cell.

7. The method of claim 6 , wherein the skin keloid fibroblast cell is ATCC deposit number CRL-1762.

8. The human pluripotent embryonic stem cells culture of claim 5 , where the human feeder cell is a fetal skin fibroblast cell.

9. A method of maintaining a human embryonic stem cell culture, comprising the steps of:

(a) isolating cells from the inner cell mass of a blastocyst;

(b) plating the inner cell mass cells, wherein inner cell mass-derived cell masses are formed; and

(c) re-plating and maintaining the human embryonic stem cell colony on a human feeder cell layer, wherein the human feeder cell is selected from the group consisting of a fetal skin fibroblast cell and a skin keloid fibroblast cell, thereby maintaining a human embryonic stem cell in an undifferentiated state for at least two passages.

10. The method of claim 9 , further comprising the step of selecting a colony with the characteristics of a human embryonic stem cell after re-plating the inner cell mass cells and before re-plating the human embryonic stem cell colony.

11. A method of isolating and maintaining a human embryonic stem cell culture, comprising the steps of:

(a) isolating cells from the inner cell mass of a blastocyst;

(b) plating the inner cell mass cells on a human feeder cell, wherein the human feeder cell is selected from the group consisting of a fetal skin fibroblast cell and a skin keloid fibroblast cell, and wherein inner cell mass-derived cell masses are formed; and

(c) re-plating and maintaining the human embryonic stem cell colony on a human feeder cell to thereby isolate and maintain a human pluripotent embryonic stem cell in an undifferentiated state for at least two passages.

12. The method of claim 11 , wherein the inner cell mass-derived cells are dissociated into clusters, and re-plated on a human feeder cell, and a colony is selected with the characteristics of a human embryonic stem cell prior to re-plating the selected human embryonic stem cell colony on a human feeder cell.

13. A human pluripotent stem cell culture, comprising a human embryonic stem cell in a media comprising bFGF and a human feeder cell, wherein the human feeder cell is a bone marrow stromal cell, and wherein the human feeder cell maintains the human embryonic stem cell in an undifferentiated state for at least two passages.

14. The human pluripotent embryonic stem cell culture of claim 13 , wherein the bone marrow stromal cell is ATCC deposit number CRL-11882.

15. A method of maintaining a human embryonic stem cell culture in an undifferentiated state for at least two passages, comprising culturing a human embryonic stem cell in a media comprising bFGF and on a human feeder cell layer, wherein the human feeder cell is a bone marrow stromal cell.

16. The method of claim 15 , wherein the bone marrow stromal cell is ATCC deposit number CRL-11882.

17. A method of maintaining a human embryonic stem cell culture, comprising the steps of:

(a) isolating cells from the inner cell mass of a blastocyst;

(b) plating the inner cell mass cells in a media comprising bFGF, wherein inner cell mass-derived cell masses are formed; and

(c) re-plating in a media comprising bFGF and maintaining the human embryonic stem cell colony on a human feeder cell layer, wherein the human feeder cell is a bone marrow stromal cell, thereby maintaining a human embryonic stem cell in an undifferentiated state for at least two passages.

18. The method of claim 17 , further comprising the step of selecting a colony with the characteristics of a human embryonic stem cell after re-plating the inner cell mass cells and before re-plating the human embryonic stem cell colony.

19. A method of isolating and maintaining a human embryonic stem cell culture, comprising the steps of:

(a) isolating cells from the inner cell mass of a blastocyst;

(b) plating the inner cell mass cells in a media comprising bEGE and on a human feeder cell, wherein the human feeder cell is a bone marrow stromal cell, and wherein inner cell mass-derived cell masses are formed; and

(c) re-plating in a media comprising bFGF and maintaining the human embryonic stem cell colony on a human feeder cell to thereby isolate and maintain a human pluripotent embryonic stem cell in an undifferentiated state for at least two passages.

20. The method of claim 19 , wherein the inner cell mass-derived cells are dissociated into clusters, and re-plated on a human feeder cell, and a colony is selected with the characteristics of a human embryonic stem cell prior to re-plating the selected human embryonic stem cell colony on a human feeder cell.

21. The method of claim 20 , wherein the inner cell mass-derived cells are dissociated into clusters, and re-plated on a human feeder cell, and a colony is selected with the characteristics of a human embryonic stem cell prior to re-plating the selected human embryonic stem cell colony on a human feeder cell.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2013
From: VIACYTE GEORGIA, INC.
To: VIACYTE, INC.
Reel/Frame 031168/0790 →
CHANGE OF NAME Recorded Apr 16, 2011
From: BRESAGEN, INC.
To: VIACYTE GEORGIA, INC.
Reel/Frame 026139/0223 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2008
From: MITALIPOVA, MAISAM; LYONS, IAN
To: BRESAGEN INC.
Reel/Frame 021413/0338 →
Continuity (1)
Related Publication 20050037488A1 · Feb 17, 2005